Skip to main content

Table 2 Peri-procedural details and hospital stay

From: Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures

 

SAVR + CABG

TAVR + OP/MIDCAB

TAVR + PCI

p-value (across groups)

(n = 464)

(n = 50)

(n = 112)

mean ± SD or median (IQR) or n (%)

mean ± SD or median (IQR) or n (%)

mean ± SD or median (IQR) or n (%)

Access route

< 0.001

 Transfemoral

n.a.

0 (0.0)

41 (36.6)

 Transapical

n.a.

29 (58.0)

70 (62.5)

 Transaortic

n.a.

21 (42.0)

1 (0.9)

Prosthesis diameter (mm)

23.7 ± 2.3

26.1 ± 2.1

25.8 ± 2.1

< 0.001

23 (23–25)

26 (26–29)

26 (23–27)

Total intervention time (min)

221 (190–245)

175 (146–231)

67 (53–83)

< 0.001

Total length of hospital stay (d)

12.0 (9.0–17.0)

11.0 (7.0–20.0)

10.0 (7.0–15.0)

0.011

Length of ICU stay (d)

1.0 (1.0–4.0)

1.0 (1.0–4.0)

1.0 (1.0–1.0)

0.001

Erythrocyte packs/patient

2.7 ± 3.9

3.6 ± 4.29

1.7 ± 2.9

0.001